Statins for primary prevention in adults aged 30–50 years with moderate cardiovascular risk: quantitative benefit, harms, and evidence gaps. // Next Research. – URL: https://www.sciencedirect.com/science/article/pii/S3050475926013205?dgcid=rss_sd_all
Statins for primary prevention in adults aged 30–50 years with moderate cardiovascular risk: quantitative benefit, harms, and evidence gaps. Next Research. https://www.sciencedirect.com/science/article/pii/S3050475926013205?dgcid=rss_sd_all
“Statins for primary prevention in adults aged 30–50 years with moderate cardiovascular risk: quantitative benefit, harms, and evidence gaps.” Next Research.
@article{article28809,
title = {Statins for primary prevention in adults aged 30–50 years with moderate cardiovascular risk: quantitative benefit, harms, and evidence gaps},
journal = {Next Research},
url = {https://www.sciencedirect.com/science/article/pii/S3050475926013205?dgcid=rss_sd_all}
}